{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:06:21Z","timestamp":1784055981748,"version":"3.55.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The pathogenesis of multiple sclerosis (MS) remains incompletely elucidated. Semaphorins play an active role in the immune and nervous systems by regulating receptor-mediated adhesion mechanisms. Immunosemaphorins have recently emerged as diagnostic biomarkers or therapeutic targets in MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to investigate alterations in semaphorins (Sema) 3A, 3F, 4A, 4D, and 7A in newly diagnosed, treatment-naive patients with relapsing\u2013remitting multiple sclerosis (RRMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective case\u2013control study, semaphorin levels were evaluated by enzyme-linked immunosorbent assay in 40 consecutive patients (serum and cerebrospinal fluid (CSF)) and 40 healthy controls (serum).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum levels of Sema3A, Sema4A, Sema4D, and Sema7A were lower in RRMS patients than in healthy controls and remained significant after correction for multiple testing. In exploratory analyses, OCB count was negatively correlated with serum Sema4A and Sema7A and positively correlated with CSF Sema7A. Patients with an OCB count \u226512 had lower serum levels of Sema3F, Sema4A, and Sema7A. Sema4D levels were higher in patients with an IgG index \u22650.7. Patients with infratentorial lesions had lower serum Sema4A levels and higher CSF Sema4A levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Low serum levels of Sema3A may be diagnostically relevant in RRMS. Low serum levels of Sema7A and elevated CSF levels may be associated with inflammatory immune activation. Further studies are needed for Sema3F, Sema4A, and Sema4D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1851383","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:17:49Z","timestamp":1784053069000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing\u2013remitting multiple sclerosis: a case\u2013control study"],"prefix":"10.3389","volume":"17","author":[{"given":"Furkan","family":"Sar\u0131da\u015f","sequence":"first","affiliation":[{"name":"Department of Neurology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birnur","family":"Ayd\u0131n","sequence":"additional","affiliation":[{"name":"Department of Physiology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"\u00d6zpar","sequence":"additional","affiliation":[{"name":"Department of Radiology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Rabia","family":"Ko\u00e7","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahattin","family":"Hakyemez","sequence":"additional","affiliation":[{"name":"Department of Radiology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fclin","family":"Alkan","sequence":"additional","affiliation":[{"name":"Department of Physiology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer Faruk","family":"Turan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bursa Uluda\u011f University Medicine Faculty","place":["Bursa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6448-2_1","article-title":"Semaphorins and their signaling mechanisms","volume":"1493","author":"Alto","year":"2017","journal-title":"Methods Mol Biol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5152\/eurjrheum.2017.17076","article-title":"Semaphorin3A: a potential therapeutic tool in immune-mediated diseases","volume":"5","author":"Vadasz","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1016\/j.febslet.2011.03.033","article-title":"The role of immune semaphorins in multiple sclerosis","volume":"585","author":"Okuno","year":"2011","journal-title":"FEBS Lett"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fimmu.2020.00346","article-title":"Semaphorins in angiogenesis and autoimmune diseases: therapeutic targets?","volume":"11","author":"Iragavarapu-Charyulu","year":"2020","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"107556","DOI":"10.1016\/j.intimp.2021.107556","article-title":"The role of immune semaphorins in the pathogenesis of multiple sclerosis: potential therapeutic targets","volume":"95","author":"Lotfi","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.molmed.2013.01.003","article-title":"Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis","volume":"19","author":"Eixarch","year":"2013","journal-title":"Trends Mol Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-008-9263-7","article-title":"Immune semaphorins: novel features of neural guidance molecules","volume":"29","author":"Mizui","year":"2009","journal-title":"J Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12016-013-8360-4","article-title":"Semaphorins: their dual role in regulating immune-mediated diseases","volume":"47","author":"Vadasz","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/eji.200535601","article-title":"Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization","volume":"36","author":"Lepelletier","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1089\/scd.2009.0212","article-title":"Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell","volume":"19","author":"Lepelletier","year":"2010","journal-title":"Stem Cells Dev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1093\/brain\/awm202","article-title":"Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?","volume":"130","author":"Williams","year":"2007","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e10378","DOI":"10.15252\/emmm.201910378","article-title":"Disruption of Sema3A\/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination","volume":"11","author":"Biname","year":"2019","journal-title":"EMBO Mol Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/mi.2012.18","article-title":"Neuroimmune semaphorin 4A downregulates the severity of allergic response","volume":"5","author":"Nkyimbeng-Takwi","year":"2012","journal-title":"Mucosal Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.immuni.2005.01.014","article-title":"Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1\/Th2 regulation in Sema4A-deficient mice","volume":"22","author":"Kumanogoh","year":"2005","journal-title":"Immunity"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.3390\/ijms21186965","article-title":"Semaphorin4A-Plexin D1 Axis induces Th2 and Th17 while represses Th1 skewing in an autocrine manner","volume":"21","author":"Carvalheiro","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"144637","DOI":"10.1016\/j.gene.2020.144637","article-title":"Semaphorin 4A, 4C, and 4D: function comparison in the autoimmunity, allergy, and cancer","volume":"746","author":"Rajabinejad","year":"2020","journal-title":"Gene"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01037","article-title":"Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2","volume":"419","author":"Kumanogoh","year":"2002","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2013.12.014","article-title":"Sema4A inhibits the therapeutic effect of IFN-\u03b2 in EAE","volume":"268","author":"Koda","year":"2014","journal-title":"J Neuroimmunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.it.2012.01.008","article-title":"Diverse roles for semaphorin-plexin signaling in the immune system","volume":"33","author":"Takamatsu","year":"2012","journal-title":"Trends Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","article-title":"Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling","volume":"13","author":"Kumanogoh","year":"2000","journal-title":"Immunity"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ncb1416","article-title":"Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis","volume":"8","author":"Takegahara","year":"2006","journal-title":"Nat Cell Biol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s000180050252","article-title":"CD100 is a leukocyte semaphorin","volume":"54","author":"Delaire","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nbd.2014.10.008","article-title":"SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease","volume":"73","author":"Smith","year":"2015","journal-title":"Neurobiol Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08916930601118890","article-title":"Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis","volume":"40","author":"Nakano","year":"2007","journal-title":"Autoimmunity"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"123281","DOI":"10.1016\/j.lfs.2024.123281","article-title":"Semaphorins and its receptors: emerging cellular biomarkers and therapeutic targets in autoimmune and inflammatory disorders","volume":"361","author":"Qamar","year":"2025","journal-title":"Life Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/art.39086","article-title":"Semaphorin 4D contributes to rheumatoid arthritis by inducing inflammatory cytokine production: pathogenic and therapeutic implications","volume":"67","author":"Yoshida","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jid.2017.09.005","article-title":"CD100\u2013Plexin-B2 promotes the inflammation in psoriasis by activating NF-\u03baB and the inflammasome in keratinocytes","volume":"138","author":"Zhang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4049\/jimmunol.1403038","article-title":"mTOR complex signaling through the SEMA4A-Plexin B2 Axis is required for optimal activation and differentiation of CD8+ T cells","volume":"195","author":"Ito","year":"2015","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4049\/jimmunol.0903302","article-title":"Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis","volume":"184","author":"Okuno","year":"2010","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4049\/jimmunol.172.2.1246","article-title":"Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells","volume":"172","author":"Giraudon","year":"2004","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"149275","DOI":"10.1016\/j.brainres.2024.149275","article-title":"Microglia-astrocyte crosstalk is regulated by Astragalus polysaccharides mediated through suppression of Sema4D-PlexinB2 signaling in experimental autoimmune encephalomyelitis","volume":"1845","author":"Ma","year":"2024","journal-title":"Brain Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nature05652","article-title":"Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin","volume":"446","author":"Suzuki","year":"2007","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ni1553","article-title":"Semaphorins and their receptors in immune cell interactions","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2015.12.005","article-title":"Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: implications for a therapeutic design","volume":"163","author":"Gutierrez-Franco","year":"2016","journal-title":"Clin Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1007\/s12035-016-0154-2","article-title":"Semaphorin 7A as a potential therapeutic target for multiple sclerosis","volume":"54","author":"Gutierrez-Franco","year":"2017","journal-title":"Mol Neurobiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e24170","DOI":"10.1002\/jcla.24170","article-title":"Investigation of serum levels of orexin-a, transforming growth factor \u03b2, and leptin in patients with multiple sclerosis","volume":"36","author":"Moharami","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.22074\/cellj.2018.4842","article-title":"Semaphorin-3A as an immune modulator is suppressed by MicroRNA-145-5p","volume":"20","author":"Rezaeepoor","year":"2018","journal-title":"Cell J"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2017.02.013","article-title":"Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients","volume":"610","author":"Rezaeepoor","year":"2017","journal-title":"Gene"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"109017","DOI":"10.1016\/j.clim.2022.109017","article-title":"The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis","volume":"238","author":"Eiza","year":"2022","journal-title":"Clin Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/01616412.2020.1774211","article-title":"Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and \u03b21 integrin in treated-multiple sclerosis patients","volume":"42","author":"Shapoori","year":"2020","journal-title":"Neurol Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jneuroim.2014.08.058","article-title":"Investigation of Sema4A as a biomarker for treatment selection for multiple sclerosis","volume":"275","author":"Kodaa","year":"2014","journal-title":"J Neuroimmunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/cen3.12490","article-title":"Semaphorin 4A as a biomarker of multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"10","author":"Okuno","year":"2019","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12974-020-01757-w","article-title":"Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase","volume":"17","author":"Koda","year":"2020","journal-title":"J Neuroinflammation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"972","DOI":"10.5692\/clinicalneurol.54.972","article-title":"Sema4A as a biomarker predicting responsiveness to IFN beta treatment","volume":"54","author":"Nakatsuji","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.4049\/jimmunol.1102023","article-title":"Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-\u03b2 therapy in multiple sclerosis","volume":"188","author":"Nakatsuji","year":"2012","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/glia.23313","article-title":"Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: a novel neuro-immune axis","volume":"66","author":"Chiou","year":"2018","journal-title":"Glia"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10517-014-2533-x","article-title":"Semaforin Sema4D in the immune system in multiple sclerosis","volume":"157","author":"Kuklina","year":"2014","journal-title":"Bull Exp Biol Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1038\/s41598-021-82388-w","article-title":"Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis","volume":"11","author":"Mosleth","year":"2021","journal-title":"Sci Rep"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12974-014-0181-8","article-title":"Validation of semaphorin 7A and ala-\u03b2-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis","volume":"11","author":"Canto","year":"2014","journal-title":"J Neuroinflammation"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1851383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:17:51Z","timestamp":1784053071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1851383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":50,"alternative-id":["10.3389\/fneur.2026.1851383"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1851383","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"1851383"}}